Skip to Content

News: anti-angiogenesis inhibitor

Tricky Tumors’ Blood Supply Targeted

Friday, October 15th, 2010

Lung cancer and the brain cancer glioblastoma multiforme are aggressive and notoriously difficult tumors to treat. If the tumors cannot be surgically removed, patients with these tumors typically survive only about one year after diagnosis. Both tumor types are resistant to radiation and are highly angiogenic (have rapidly growing blood vessels). Therefore, anti-angiogenesis therapies may […]